The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug-Eluting Bioabsorbable Stents Market Research Report 2025
Synopsis
The global Drug-Eluting Bioabsorbable Stents market was valued at US$ 894.2 million in 2023 and is anticipated to reach US$ 1217.4 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug-Eluting Bioabsorbable Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Eluting Bioabsorbable Stents.
Report Scope
The Drug-Eluting Bioabsorbable Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug-Eluting Bioabsorbable Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug-Eluting Bioabsorbable Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
Segment by Type
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Segment by Application
Coronary Artery Diseases
Peripheral Artery Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug-Eluting Bioabsorbable Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug-Eluting Bioabsorbable Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Drug-Eluting Bioabsorbable Stents market was valued at US$ 894.2 million in 2023 and is anticipated to reach US$ 1217.4 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug-Eluting Bioabsorbable Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Eluting Bioabsorbable Stents.
Report Scope
The Drug-Eluting Bioabsorbable Stents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug-Eluting Bioabsorbable Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug-Eluting Bioabsorbable Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
B.Braun Melsungen
Abbott Laboratories
Boston Scientific Corporation
Biosensors International
Terumo Corporation.
MicroPort Scientific Corporation
Alvimedica
Biotronik
Elixir Medical Corporation
Innovative Health Technologies
Segment by Type
Serolimus and Paclitaxel Drug-Eluting Stents
Sirolimus Drug Eluting Stents
Segment by Application
Coronary Artery Diseases
Peripheral Artery Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug-Eluting Bioabsorbable Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug-Eluting Bioabsorbable Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Drug-Eluting Bioabsorbable Stents Market Overview
1.1 Product Overview and Scope of Drug-Eluting Bioabsorbable Stents
1.2 Drug-Eluting Bioabsorbable Stents Segment by Type
1.2.1 Global Drug-Eluting Bioabsorbable Stents Market Value Comparison by Type (2024-2030)
1.2.2 Serolimus and Paclitaxel Drug-Eluting Stents
1.2.3 Sirolimus Drug Eluting Stents
1.3 Drug-Eluting Bioabsorbable Stents Segment by Application
1.3.1 Global Drug-Eluting Bioabsorbable Stents Market Value by Application: (2024-2030)
1.3.2 Coronary Artery Diseases
1.3.3 Peripheral Artery Diseases
1.4 Global Drug-Eluting Bioabsorbable Stents Market Size Estimates and Forecasts
1.4.1 Global Drug-Eluting Bioabsorbable Stents Revenue 2019-2030
1.4.2 Global Drug-Eluting Bioabsorbable Stents Sales 2019-2030
1.4.3 Global Drug-Eluting Bioabsorbable Stents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug-Eluting Bioabsorbable Stents Market Competition by Manufacturers
2.1 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug-Eluting Bioabsorbable Stents Average Price by Manufacturers (2019-2024)
2.4 Global Drug-Eluting Bioabsorbable Stents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug-Eluting Bioabsorbable Stents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug-Eluting Bioabsorbable Stents, Product Type & Application
2.7 Drug-Eluting Bioabsorbable Stents Market Competitive Situation and Trends
2.7.1 Drug-Eluting Bioabsorbable Stents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug-Eluting Bioabsorbable Stents Players Market Share by Revenue
2.7.3 Global Drug-Eluting Bioabsorbable Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug-Eluting Bioabsorbable Stents Retrospective Market Scenario by Region
3.1 Global Drug-Eluting Bioabsorbable Stents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug-Eluting Bioabsorbable Stents Global Drug-Eluting Bioabsorbable Stents Sales by Region: 2019-2030
3.2.1 Global Drug-Eluting Bioabsorbable Stents Sales by Region: 2019-2024
3.2.2 Global Drug-Eluting Bioabsorbable Stents Sales by Region: 2025-2030
3.3 Global Drug-Eluting Bioabsorbable Stents Global Drug-Eluting Bioabsorbable Stents Revenue by Region: 2019-2030
3.3.1 Global Drug-Eluting Bioabsorbable Stents Revenue by Region: 2019-2024
3.3.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Region: 2025-2030
3.4 North America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
3.4.1 North America Drug-Eluting Bioabsorbable Stents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2030)
3.4.3 North America Drug-Eluting Bioabsorbable Stents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
3.5.1 Europe Drug-Eluting Bioabsorbable Stents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2030)
3.5.3 Europe Drug-Eluting Bioabsorbable Stents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
3.6.1 Asia Pacific Drug-Eluting Bioabsorbable Stents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug-Eluting Bioabsorbable Stents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
3.7.1 Latin America Drug-Eluting Bioabsorbable Stents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2030)
3.7.3 Latin America Drug-Eluting Bioabsorbable Stents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug-Eluting Bioabsorbable Stents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug-Eluting Bioabsorbable Stents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug-Eluting Bioabsorbable Stents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug-Eluting Bioabsorbable Stents Sales by Type (2019-2030)
4.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Type (2019-2024)
4.1.2 Global Drug-Eluting Bioabsorbable Stents Sales by Type (2025-2030)
4.1.3 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Type (2019-2030)
4.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2019-2030)
4.2.1 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2019-2024)
4.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Type (2025-2030)
4.2.3 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Type (2019-2030)
4.3 Global Drug-Eluting Bioabsorbable Stents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug-Eluting Bioabsorbable Stents Sales by Application (2019-2030)
5.1.1 Global Drug-Eluting Bioabsorbable Stents Sales by Application (2019-2024)
5.1.2 Global Drug-Eluting Bioabsorbable Stents Sales by Application (2025-2030)
5.1.3 Global Drug-Eluting Bioabsorbable Stents Sales Market Share by Application (2019-2030)
5.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2019-2030)
5.2.1 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2019-2024)
5.2.2 Global Drug-Eluting Bioabsorbable Stents Revenue by Application (2025-2030)
5.2.3 Global Drug-Eluting Bioabsorbable Stents Revenue Market Share by Application (2019-2030)
5.3 Global Drug-Eluting Bioabsorbable Stents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Drug-Eluting Bioabsorbable Stents Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 B.Braun Melsungen
6.2.1 B.Braun Melsungen Corporation Information
6.2.2 B.Braun Melsungen Description and Business Overview
6.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Portfolio
6.2.5 B.Braun Melsungen Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Boston Scientific Corporation
6.4.1 Boston Scientific Corporation Corporation Information
6.4.2 Boston Scientific Corporation Description and Business Overview
6.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Portfolio
6.4.5 Boston Scientific Corporation Recent Developments/Updates
6.5 Biosensors International
6.5.1 Biosensors International Corporation Information
6.5.2 Biosensors International Description and Business Overview
6.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biosensors International Drug-Eluting Bioabsorbable Stents Product Portfolio
6.5.5 Biosensors International Recent Developments/Updates
6.6 Terumo Corporation.
6.6.1 Terumo Corporation. Corporation Information
6.6.2 Terumo Corporation. Description and Business Overview
6.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Portfolio
6.6.5 Terumo Corporation. Recent Developments/Updates
6.7 MicroPort Scientific Corporation
6.6.1 MicroPort Scientific Corporation Corporation Information
6.6.2 MicroPort Scientific Corporation Description and Business Overview
6.6.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Portfolio
6.7.5 MicroPort Scientific Corporation Recent Developments/Updates
6.8 Alvimedica
6.8.1 Alvimedica Corporation Information
6.8.2 Alvimedica Description and Business Overview
6.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Alvimedica Drug-Eluting Bioabsorbable Stents Product Portfolio
6.8.5 Alvimedica Recent Developments/Updates
6.9 Biotronik
6.9.1 Biotronik Corporation Information
6.9.2 Biotronik Description and Business Overview
6.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biotronik Drug-Eluting Bioabsorbable Stents Product Portfolio
6.9.5 Biotronik Recent Developments/Updates
6.10 Elixir Medical Corporation
6.10.1 Elixir Medical Corporation Corporation Information
6.10.2 Elixir Medical Corporation Description and Business Overview
6.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Portfolio
6.10.5 Elixir Medical Corporation Recent Developments/Updates
6.11 Innovative Health Technologies
6.11.1 Innovative Health Technologies Corporation Information
6.11.2 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Description and Business Overview
6.11.3 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Portfolio
6.11.5 Innovative Health Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug-Eluting Bioabsorbable Stents Industry Chain Analysis
7.2 Drug-Eluting Bioabsorbable Stents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug-Eluting Bioabsorbable Stents Production Mode & Process
7.4 Drug-Eluting Bioabsorbable Stents Sales and Marketing
7.4.1 Drug-Eluting Bioabsorbable Stents Sales Channels
7.4.2 Drug-Eluting Bioabsorbable Stents Distributors
7.5 Drug-Eluting Bioabsorbable Stents Customers
8 Drug-Eluting Bioabsorbable Stents Market Dynamics
8.1 Drug-Eluting Bioabsorbable Stents Industry Trends
8.2 Drug-Eluting Bioabsorbable Stents Market Drivers
8.3 Drug-Eluting Bioabsorbable Stents Market Challenges
8.4 Drug-Eluting Bioabsorbable Stents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
